Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
3.350
-0.009 (-0.27%)
At close: Oct 27, 2026, 4:00 PM EDT
3.400
+0.050 (1.49%)
After-hours: Oct 27, 2026, 6:26 PM EDT
Passage Bio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Passage Bio stock has a consensus rating of "Buy" and an average price target of $15.5. The average 1-year stock price forecast is 362.69% higher than the current stock price, while the lowest is $8.00 (+138.81%) and the highest is $23 (+586.57%).
Price Target: $15.5 (+362.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Passage Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 4 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 5 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 11, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-14.08
from -14.35
EPS Next Year
-11.55
from -14.08
EPS and Forward PE are based on non-GAAP adjusted numbers.